NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

NCT04976322

Enrolling By InvitationPhase 3

Sponsor: UCB Biopharma SRL

Conditions: Systemic Lupus Erythematosus

Interventions: Dapirolizumab pegol

Countries: United States, Argentina, Belgium, Bulgaria, Canada, Chile, China, Colombia

The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.

Eligibility overview

Sex: ALL

Age: 16 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* The participant could, in the opinion of the Investigator, benefit from long-term dapirolizumab pegol (DZP) treatment
* The participant completed one of the parent studies within 4 weeks prior to entry to this study

Exclusion Criteria:

\- Study participant has any medical or psychiatric condition (including conditions due to neuropsychiatric systemic lupus erythematosus (SLE)) that, in the opinion of the Investigator, could jeopardize or would compromise the study participant's ability to participate in this study. This includes study participants with a life-threatening condition or ongoing malignancies at the start of the study
Locations (118)
  • Birmingham, Alabama, United States
  • Avondale, Arizona, United States
  • Glendale, Arizona, United States
  • Phoenix, Arizona, United States
  • Tucson, Arizona, United States
  • Beverly Hills, California, United States
  • La Palma, California, United States
  • San Leandro, California, United States
  • Denver, Colorado, United States
  • Brandon, Florida, United States
  • Gainesville, Florida, United States
  • Miami, Florida, United States
  • Ormond Beach, Florida, United States
  • Plantation, Florida, United States
  • Tampa, Florida, United States
  • Tampa, Florida, United States
  • Atlanta, Georgia, United States
  • Idaho Falls, Idaho, United States
  • Hopkinsville, Kentucky, United States
  • Lake Charles, Louisiana, United States
  • Hagerstown, Maryland, United States
  • Detroit, Michigan, United States
  • Las Vegas, Nevada, United States
  • Canton, New York, United States
  • Manhasset, New York, United States
  • New York, New York, United States
  • Charlotte, North Carolina, United States
  • Hershey, Pennsylvania, United States
  • Jackson, Tennessee, United States
  • Colleyville, Texas, United States
  • + 88 more on CT.gov